About CRV Partners
CR Ventures’ investment model offers portfolio companies preferred access to a network of CROs and other service providers crucial to the success of clinical stage biotech companies. Our vetted partners offer our portfolio companies top-level management attention, rapid efficient study enrollment and completion, and capital efficiency. Partners are also investors in CRV. This reduces risk by aligning interests of all parties.
Select Corporate Partners
2CA Braga
2CA Braga offers a full range of CRO and clinical site services within the Hospital de Braga and the cluster of medical school of University of Minho, Portugal.
2CA has access to a broad range of patients, the reputation of a major academic center, and a substantial catchment area, offering companies rapid recruitment, quality care, and capital efficiency.
Oncology
CR Ventures partners include high-reputation oncology centers in Europe and the United States.
Challenging Studies
CR Ventures partners include high-reputation research hospitals in the United States.
CRU Global
Our clinical partner CRU Global is a top-tier network of clinical research sites, with over 250 Phase I to III trials completed for Pfizer, Novartis, Merck (American), GSK, Amgen, AstraZeneca, and others. CRU Global has an excellent track record for rapid patient enrollment (often the top world-wide enroller in multi-site trials), with >95% recruitment targets met or exceeded, >95% patient retention, and industry-leading success/completion rates. CRU Global also offers medical writing, regulatory preparation and submission, and most other tasks involved in carrying a drug or device through clinical development.
Representative CRU Global clinical studies:
| CRO | Sponsor | Therapy area | Protocol No. |
| MSD Pharma Hungary Kft | MSD | Non Small Cell Lung Cancer | MK-7902-007-01 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Colitis Ulcerosa | M16-066 |
| PRA Magyarország Kft. | F. Hoffmann-La Roche AG | Hepatic Impairment | GP41174 |
| IQVIA Biotech | Milestone Pharmaceuticals Inc. | Cardiovascular outcomes studies | NODE-303 |
| IQVIA Biotech | Eli Lilly and Compary | Rheumatoid arthritis | I4V-MC-JAJA |
| August Research | Cirius Therapeutics, Inc. | Diabetes/ obesity in diabetes | CTI-0602K-C013 |
| PRA Magyarország Kft. | Bristol-Myers Squibb Company | Psoriatic Arthritis | IM011084 |
| PAREXEL Magyarország Kft. | Pfizer Inc. | Diabetes/ obesity in diabetes | C3421005 |
| PAREXEL Magyarország Kft. | Pfizer Inc. | Dermatitis | B7931022 |
| MSD Pharma Hungary Kft | MSD | Non Small Cell Lung Cancer | MK-7902-007-01 |
| Amgen Kft. | Amgen Kft. | Dermatitis | 20170755 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Non Small Cell Lung Cancer | M14-239 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Colitis Ulcerosa | M16-066 |
| PSI CRO Hungary | Celgene International II Sàrl | Crohn Disease | RPC01-3203 |
| PSI CRO Hungary | Celgene International II Sàrl | Crohn Disease | RPC01-3204 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Colitis Ulcerosa | M16-067 |
| Amgen Kft. | Amgen Kft. | Hypercholesterolemia | 20170625 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-430 |
| Worldwide Clinical Trials | KBP Biosciences Co. Ltd. | Hypertension | KBP-5074-2-001 |
| Syneos Health UK Limited | Summit (Oxford) Limited | Clostridium | SMT19969/C004 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Psoriatic Arthritis | M15-998 |
| HungaroTrial | MedDay Pharmaceuticals SA | Hepatic Impairment | OP107719.MED |
| HungaroTrial | MedDay Pharmaceuticals SA | Renal Impairment | OP107819.MED |
| KCR S.A. | BiondVax Pharmaceuticals Ltd. | Influenza | BVX-010_2 |
| CPS Cortex Kft. | Abivax | Rheumatoid arthritis | ABX464-301 |
| PRA Magyarország Kft. | Estetra SPRL | Hepatic Impairment | MIT-Do001-C102 |
| PRA Magyarország Kft. | Bristol-Myers Squibb Company | Hepatic Impairment | IM011-062 |
| PRA Magyarország Kft. | BIAL | Hepatic Impairment | BIA-51058-113 |
| PRA Magyarország Kft. | BIAL | Renal Impairment | BIA-51058-114 |
| PSI CRO Hungary | Celgene International II Sàrl | Crohn Disease | RPC01-3202 |
| Cromos Pharma | Umecrine Cognition AB | Hepatic Impairment | UCAB-CT-02 |
| COVANCE Hungária Kft. | CSL Behring GmBH | Acute Coronary Syndrome | CSL12_3001 |
| MSD Pharma Hungary Kft | MSD | Chronic cough | MK 7264-027 |
| MSD Pharma Hungary Kft | MSD | Chronic cough | MK 7264-030 |
| Cromos Pharma | Umecrine Cognition AB | Hepatic Impairment | UCAB-CT-02 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | M16-560 |
| PRA Magyarország Kft. | Bristol-Myers Squibb Company | Hepatic Impairment | CV013026 |
| AstraZeneca | AstraZeneca | Cardiovascular outcomes studies | D169CC00001 |
| Pfizer Hungary | Pfizer Inc. | Non Small Cell Lung Cancer | B991023 |
| TFS | Novartis Hungária Kft. | Psoriatic Arthritis | CAIN457F2354 |
| PRA Magyarország Kft. | Avanir Pharmaceuticals Inc. | Alzheimer Disease | 17-AVP-786-305 |
| PAREXEL Magyarország Kft. | Pfizer Inc. | Non Small Cell Lung Cancer | B9991025 |
| TFS | Galapagos NV | Dermatitis | MOR106-CL-201 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-430 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Small Cell Lung Cancer | M16-298 |
| PRA Magyarország Kft. | Bristol-Myers Squibb Company | Renal Impairment | MB130065 |
| AstraZeneca | AstraZeneca | Other cardiovascular | D9484C00001 |
| Quintiles Switzerland Sárl | GlaxoSmithKline Kft. | COPD | 2014N206201_00 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-431 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-431 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-433 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-433 |
| inVentiv Health Hungary | Pfizer Inc. | Hematology | A4091061 |
| ZAK-Pharma | Boehringer Ingelheim | Alzheimer Disease | BI 425809 |
| PAREXEL Magyarország Kft. | Pfizer Inc. | Cardiovascular outcomes studies | B1521021 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | M16-763 |
| Amgen Kft. | Amgen Kft. | Cardiovascular outcomes studies | 20130295 |
| MSD Pharma Hungary Kft | MSD | Non Small Cell Lung Cancer | MK-3475-715 |
| ICON Klinikai Kutató Kft. | Pfizer Inc. | Dermatitis | B7451015 |
| PAREXEL Magyarország Kft. | UCB Pharma Ltd | Psoriasis | PS0014 |
| Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Schizophrenia | R092670PSY3015 |
| Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Schizophrenia | R092670PSY3015 |
| Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Schizophrenia | R092670PSY3015 |
| Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Schizophrenia | R092670PSY3015 |
| Medpace Inc | DalCore Pharma UK Ltd. | Cardiovascular outcomes studies | DAL-301 |
| ICON Klinikai Kutató Kft. | Pfizer Inc. | Clostridium | B5091007 |
| PAREXEL Magyarország Kft. | UCB Pharma Ltd | Psoriasis | PS0013 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | M16-063 |
| PRA Magyarország Kft. | Gan & Lee Pharmaceuticals | Diabetes/ obesity in diabetes | GL-GLAT1-3001 |
| Clinipace Worldwide | SHIELD Therapeutics | Anemia | ST10-01-304 |
| PAREXEL Magyarország Kft. | AstraZeneca | Asthma | D3741C00007 |
| PAREXEL Magyarország Kft. | AstraZeneca | Asthma | D3741C00007 |
| PSI CRO Hungary | Basilea Pharmaceutica International Ltd | Dermatitis | BPR-CS-008 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | MTX-IR M14-465 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | MTX-native M13-545 |
| ICON Klinikai Kutató Kft. | Pfizer Inc. | Dermatitis | B7451012 |
| Novartis Hungária Kft. | Novartis Hungária Kft. | Asthma | CQVM149B2301 |
| HungaroTrial | Chiesi Farmaceutici S.p.A. | COPD | CLI-05993BA102 |
| ZAK-Pharma | Boehringer Ingelheim | Embolic Stroke | BI1160.189 |
| PAREXEL Magyarország Kft. | Pfizer Inc. | Rheumatoid arthritis | B7984006 |
| inVentiv Health Hungary | Pfizer Inc. | Low Back Pain | A4091059 |
| INC Research UK Limited | Biotest AG | Hematology | 992 |
| INC Research UK Limited | Biotest AG | Hematology | 992 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Non Small Cell Lung Cancer | M14-359 |
| MSD Pharma Hungary Kft | Merck Sharp and Dohme | Non Small Cell Lung Cancer | MK-3475-024 |
| PRA Magyarország Kft. | Mitshubishi Tanabe Pharma | Hepatic Impairment | MCI-186-E05 |
| KCR S.A. | BiondVax Pharmaceuticals Ltd. | Influenza | BVX-010 |
| COVANCE Hungária Kft. | AstraZeneca | Diabetes/ obesity in diabetes | D5670C00007 |
| Worldwide Clinical Trials | Proximagen Ltd. | Osteoarthritis | 167700-004CL |
| ZEINCRO | CERENIS Therapeutics | NASH | PROT-CER-209-CLIN-002 |
| ZEINCRO | CERENIS Therapeutics | NASH | PROT-CER-209-CLIN-002 |
| Worldwide Clinical Trials | Proximagen Ltd. | Osteoarthritis | 167700-004CL |
| Medpace Inc | IONIS PHARMACEUTICALS, INC. | Diabetes/ obesity in diabetes | IS137CS2 |
| Medpace Inc | Ironwood Pharmaceuticals, Inc. | Gout | RDEA594-401 |
| AstraZeneca | AstraZeneca | COPD | D5970C00002 |
| Worldwide Clinical Trials | Tricida Inc. | Nephropathy | TRCA-301 |
| inVentiv Health Hungary | Pfizer Inc. | Rheumatoid arthritis | A3921192 |
| Argint International | Novimmun SA | Rheumatoid arthritis | AI-CF010b |
| PAREXEL Magyarország Kft. | Pfizer Inc. | Rheumatoid arthritis | B7921005 |
| AstraZeneca | AstraZeneca | Asthma | D2500C00003 |
| Worldwide Clinical Trials | Relypsa Inc. | Hypertension | RLY5016-207 |
| AstraZeneca | AstraZeneca | COPD | PT009002-01 |
| AstraZeneca | AstraZeneca | Asthma | D3250C00038 |
| AstraZeneca | AstraZeneca | Asthma | D3250C00038 |
| CPS Cortex Kft. | Meditop Pharmaceutical Ltd. | Other | KZ-PKP-092016 |
| KCR S.A. | Luitpold Pharmaceuticals Inc. | Hematology | 1VIT14039 |
| inVentiv Health Hungary | Pfizer Inc. | Dermatitis | B7451006 |
| INC Research UK Limited | HAL Allergy B.V. | Allergic Rhinitis | PM/0041 |
| COVANCE Hungária Kft. | Polichem S.A. | pattern baldness | PM1541 |
| ICON Klinikai Kutató Kft. | Mereo BioPharma 1 Ltd | COPD | MBCT206 |
| PRA Magyarország Kft. | Amgen Kft. | Rheumatoid arthritis | 20130108 |
| PSI CRO Hungary | Achaogen Inc. | Urinary infection | ACHN-490-009 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | Biologics-IR M13-542 |
| Medpace Inc | Zavanta | Urinary infection | ZTI-01-200 |
| COVANCE Hungária Kft. | Motif BiosSciences Inc. | ABSSI | ICL-24-ABSSSI2 |
| MSD Pharma Hungary Kft | Merck Sharp and Dohme | Diabetes/ obesity in diabetes | MK431-838 |
| PSI CRO Hungary | Melinta Therapeutics | CABP | ML-3341-306 |
| Medpace Inc | IONIS PHARMACEUTICALS, INC. | Diabetes/ obesity in diabetes | 449884-CS3 |
| Orion LR Ltd. | Chiesi Farmaceutici S.p.A. | COPD | CCD-06302AA1-01 |
| Servier Hungária Kft. | Servier Hungária Kft | Hematology | CL1-55746-001 |
| INC Research UK Limited | Pharmaxis | Cystic Fibrosis | DPM-CF-303 |
| PPD Magyarország Kft. | Nabriva Therapeutics US, Inc. | CABP | NAB-BC-3781-3101 |
| inVentiv Health Hungary | Pearl Therapeutics, Inc. | COPD | PT010005 |
| Pharm-Olam (Hungary) Ltd. | Boehringer Ingelheim | Diabetes/ obesity in diabetes | BI 124572 |
| BioRasi LLC | BioRasi LLC | Other | ZIN-130-1504 |
| PSI CRO Hungary | Paratek Pharma, LLC, | CABP | PTK0796-CABP-1200 |
| Quintiles Magyarország Kft. | F. Hoffmann-La Roche AG | COPD | WB29804 |
| INC Research UK Limited | Vectura Group Plc | Asthma | Vectura_VR475 |
| PSI CRO Hungary | Paratek Pharma, LLC, | Dermatitis | PTK0796-ABSI-1108 |
| Novartis Hungária Kft. | Novartis Hungária Kft. | Asthma | CQGE031B2204 |
| MSD Pharma Hungary Kft | Merck Sharp and Dohme | Head and Neck Cancer | MK-3475-048 |
| MSD Pharma Hungary Kft | Merck Sharp and Dohme | Head and Neck Cancer | MK-3475-040 |
| AstraZeneca | AstraZeneca | Diabetes/ obesity in diabetes | D1689C0014 |
| ICON Klinikai Kutató Kft. | Chiesi Farmaceutici S.p.A. | COPD | CCD-05993AA1-07 |
| GlaxoSmithKline Kft. | GlaxoSmithKline Kft. | Diabetes/ obesity in diabetes | GLP116174 |
| Worldwide Clinical Trials | Ablynx NV | Rheumatoid arthritis | ALX0061-C203 |
| Medpace Inc | Astellas Pharma Europe | Diabetes/diabetic nephropathy | 8232-CL-0004 |
| Medpace Inc | Astellas Pharma Europe | Diabetes/diabetic nephropathy | 8232-CL-0004 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Non Small Cell Lung Cancer | M11-089 |
| Worldwide Clinical Trials | Ablynx NV | Rheumatoid arthritis | ALX0061-C202 |
| Worldwide Clinical Trials | Ablynx NV | Rheumatoid arthritis | ALX0061-C202 |
| Worldwide Clinical Trials | Ablynx NV | Rheumatoid arthritis | ALX-0061 C201 |
| Medpace Inc | Coherus Biosciences, Inc. | Rheumatoid arthritis | CHS-0214-02 |
| Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Type 2 diabetes | 28431754DIA4003 |
| AstraZeneca | AstraZeneca | Asthma | ‘BISE’ D3250C00032 |
| AstraZeneca | AstraZeneca | Other | D4281C00001 |
| GlaxoSmithKline Kft. | GlaxoSmithKline Kft. | COPD | CTT116853 |
| TFS | GW Pharma | Chronic Pain in Cancer | GWCA0999 |
| Medpace Inc | IONIS PHARMACEUTICALS, INC. | Hyperlipidemia/ dyslipidemia | ISIS 304801-CS6 |
| PAREXEL Magyarország Kft. | Pfizer Inc. | Type 2 diabetes | B1521017 |
| PAREXEL Magyarország Kft. | Pfizer Inc. | Type 2 diabetes | B1521017 |
| Amgen Kft. | Amgen Kft. | LDL-C abnormal lipid | 20130385 |
| MSD Pharma Hungary Kft | Merck Sharp and Dohme | Non Small Cell Lung Cancer | MK-3475-010 |
| Quintiles Magyarország Kft. | Eli Lilly and Compary | Diabetes/ obesity in diabetes | H9X-MC-GBDX |
| PAREXEL Magyarország Kft. | Synta Pharmaceuticals Corp. | Non Small Cell Lung Cancer | Galaxy 2 / 9090-14 |
| Janssen-Cilag Kft. | Janssen-Cilag International N.V. | COPD | 49095397OPD2001 |
| AstraZeneca | AstraZeneca | Asthma | D589SC00001 |
| AstraZeneca | AstraZeneca | Asthma | D589SC00003 SYGMA2 |
| PAREXEL Magyarország Kft. | Synta Pharmaceuticals Corp. | Non Small Cell Lung Cancer | Galaxy 2 / 9090-14 |
| Medpace Inc | Nephrogenex Inc. | Diabetes/diabetic nephropathy | PYR-311 |
| AstraZeneca | AstraZeneca | Asthma | D2210C00007 |
| GlaxoSmithKline Kft. | GlaxoSmithKline Kft. | COPD | DB2116961 |
| Chiltern International | Chiesi Farmaceutici S.p.A. | COPD | CCD-1207-PR-0091 |
| Chiltern International | Chiesi Farmaceutici S.p.A. | COPD | CCD-1207-PR-0091 |
| Amgen Kft. | Amgen Kft. | Osteoporosis | 20101217 |
| GlaxoSmithKline Kft. | GlaxoSmithKline Kft. | COPD | 201211 SGRQ |
| Chiltern International | Chiesi Farmaceutici S.p.A. | COPD | CCD-1208-PR-0090 |
| PRA Magyarország Kft. | Hanmi Pharmaceutical | Type 2 diabetes | HM-EXC-204 |
| TFS | GW Pharma | Chronic Pain in Cancer | GWCA1103 |
| AstraZeneca | AstraZeneca | COPD | D3251C00003 |
| TFS | GW Pharma | Chronic Pain in Cancer | GWCA1103 |
| COVANCE Hungária Kft. | MSD | Type 2 diabetes | MK-8835-001 |
| ICON Klinikai Kutató Kft. | Pfizer Inc. | SPA | A3921119 |
| Medpace Inc | Shionogi Inc. | Opioid Indication Constipation | 1326V9235 |
| Medpace Inc | Omthera Pharmaceuticals | Hypertriglyceridemia | OM-EPA-011 |
| Medpace Inc | Omthera Pharmaceuticals | Hypertriglyceridemia | OM-EPA-011 |
| Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Type 2 diabetes | 28431754DIA4003 |
| PRA Magyarország Kft. | Hanmi Pharmaceutical | Type 2 diabetes | HM-EXC-203 |
| PRA Magyarország Kft. | Ferring Pharmaceuticals | Constipation | 81 |
| TFS | Aquinox | COPD | AQX-1125-202 |
| Worldwide Clinical Trials | NEOVACS SA | Rheumatoid arthritis | TNF-K006 |
| Medpace Inc | Kowa Research Europe Ltd. | LDL-C abnormal lipid | K-877-201 |
| PRA Magyarország Kft. | Ferring Pharmaceuticals | Constipation | 80 |
| Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Type 2 diabetes | 28431754-DIA-3011 |
| Scope International | Develco Pharma | Opioid Indication Constipation | 0176/DEV |
| Scope International | Develco Pharma | Opioid Indication Constipation | 0177/DEV |
| Amgen Kft. | Amgen Kft. | LDL-C with CV outcome | 20110118 |
| Amgen Kft. | Amgen Kft. | LDL-C with CV outcome | 20110118 |
| Medpace Inc | Helsinn Therapeutics | Non Small Cell Lung Cancer | HT-ANAM-302 |
| Quintiles Magyarország Kft. | Takeda Global Research | Diabetes/diabetic nephropathy | TAK-875-302 |
| Quintiles Magyarország Kft. | Mitshubishi Tanabe Pharma | Diabetes/diabetic nephropathy | MT-3995-07 |
| Quintiles Magyarország Kft. | Vertex Pharmaceutical | Rheumatoid arthritis | VX11-509-102 |
| Quintiles Magyarország Kft. | Thrombosis Research Institute | Other | TRI08888-GARFILED |
| Medpace Inc | Helsinn Therapeutics | Non Small Cell Lung Cancer | HT-ANAM-301 |
| Medpace Inc | Helsinn Therapeutics | Non Small Cell Lung Cancer | HT-ANAM-303 |
| Worldwide Clinical Trials | Boehringer Ingelheim | Type 2 diabetes | BI 1245.25 |
| PAREXEL Magyarország Kft. | Eli Lilly and Compary | Type 2 diabetes | 108440 |
| PAREXEL Magyarország Kft. | Eli Lilly and Compary | Type 2 diabetes | 108440 |
| Medpace Inc | ChemoCentryx Inc. | Diabetes/diabetic nephropathy | CL005_140 |
| PAREXEL Magyarország Kft. | GlaxoSmithKline Kft. | COPD | HZC113782 |
| Syneos Health UK Limited | Institut de Recherches Internationales SERVIER (I.R.I.S.) | Chronic Venous Disease | CL3-05682-109 |
| INC Research UK Limited | Urovant Sciences GmbH | Overactive bladder | RVT-901-3004 |
| Accelovance Europe | Zeno Pharmaceuticals Inc. | Non Small Cell Lung Cancer | ZN-e4-001 |
| INC Research UK Limited | Urovant Sciences GmbH | Overactive bladder | RVT-901-3003 |
| PRA Magyarország Kft. | Gilead Sciences Inc. | Rheumatoid arthritis | GS-US-417-0303 |
| PRA Magyarország Kft. | Gilead Sciences Inc. | Rheumatoid arthritis | GS-US-417-0302 |
| PRA Magyarország Kft. | UCB Pharma Ltd | SPA | AS0006 |
| AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | JAKMTXIR2 |
| Linical Europe GmbH | Sun Pharmaceutical | Other | CLR_15_02 |
| COVANCE Hungária Kft. | Incyte Corporation | Non Small Cell Lung Cancer | INCB 39110-205 |
| COVANCE Hungária Kft. | Ignyta Pharma | Non Small Cell Lung Cancer | RXDX-101-02 |
| Inamed GmbH (Trial Masters) | Actavis Group PTC | Asthma | ACT-2014-075 |